These results indicate that FILIP1L inhibits angiogenesis, at least in part, by inhibiting the activity of angiogenic inducers and promoting the activity of angiogenic inhibitors in human colorectal cancer. This evidence concerns the gene FILIP1L and colorectal cancer.